Intel's record Q4 run ends with profit drop

Shame on the Americas


Intel rumbled to record revenue in its fourth quarter but saw its profit fall, as it felt the pains of competitive pressure from AMD.

Intel posted a 10 per cent increase in revenue to $9.6bn. This total marks a quarterly record for the chipmaker. Intel, however, reported that its profit fell 2 per cent year-over-year to $2.1bn - a rare drop for the company. Intel's earnings per share of 33 cents during the period beat out the consensus analysts' estimate of 31 cents per share.

For the full year, Intel's revenue hit $34.2bn - a solid 13.5 per cent year-over-year increase and also another record. Income came in at $7.5bn, which was up a stunning 33 percent over last year' s $5.6bn.

"Our investments in manufacturing capacity, innovative new products and global presence have allowed us to post double-digit gains in both revenue and profits two years in a row," said soon to be exiting CEO Craig Barrett.

Intel executives boasted about success across the company's product lines, during a conference call with analysts. The firm's results, however, did disappoint in some areas.

For one, Intel's gross profit margin fell to 56 per cent in the fourth quarter, which compares to 63.6 per cent in the same quarter a year ago. A resurgent AMD and related pricing pressure no doubt contributed to this fall.

Intel also saw a somewhat modest increase in its processor sales. The company churned out $6.8bn in chip sales during the fourth quarter versus $6.5bn last year. Its motherboard and chipset business grew revenue to $1.4bn from $1.2bn, and flash memory sales jumped to $643m from $399m. For the full year, Intel posted 12 per cent processor revenue growth but could muster just 5 per cent growth in the fourth quarter, while its two other main business were well into double-digit growth.

In addition, Intel actually saw its sales to the Americas region fall during the fourth quarter. It pulled in $2.0bn this year compared to $2.4bn last year. This drop was offset by a surge in sales to Asia-Pacific where revenue jumped to $4.4bn from $3.4bn. Sales to Europe held relatively steady at $2.3bn compared to $2.1bn one year ago.

Shares of Intel were up slightly during Tuesday's trading on the after-hours markets.

Intel is looking for first quarter revenue to come in between $8.8bn and $9.4bn. ®

Related stories

Investors gut AMD on memory slip
Toshiba announces Sonoma-based notebook early
AMD unveils Centrino spoiler
Transmeta may power down chip making biz


Other stories you might like

  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading
  • Need to prioritize security bug patches? Don't forget to scan Twitter as well as use CVSS scores

    Exploit, vulnerability discussion online can offer useful signals

    Organizations looking to minimize exposure to exploitable software should scan Twitter for mentions of security bugs as well as use the Common Vulnerability Scoring System or CVSS, Kenna Security argues.

    Better still is prioritizing the repair of vulnerabilities for which exploit code is available, if that information is known.

    CVSS is a framework for rating the severity of software vulnerabilities (identified using CVE, or Common Vulnerability Enumeration, numbers), on a scale from 1 (least severe) to 10 (most severe). It's overseen by First.org, a US-based, non-profit computer security organization.

    Continue reading

Biting the hand that feeds IT © 1998–2022